Y0002084

(S)-(-)-9,10-ジフルオロ-2,3-ジヒドロ-3-メチル-7-オキソ-7H-ピリド-[1,2,3-de]-1,4-ベンゾオキサジン-6-カルボン酸

European Pharmacopoeia (EP) Reference Standard

• 別名: (S)-(−)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
• 実験式（ヒル表記法）: C₁₃H₉F₂NO₄
• CAS番号: 100986-89-8
• 分子量: 281.21
• MDL番号: MFCD04039905
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: levofloxacin
• 光学活性: [α]20/D -64°, c = 1% in DMSO
• メーカー／製品名: EDQM
• mp: >300 °C (lit.)
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: C[C@H]1COc2c(F)c(F)cc3C(=O)C(=CN1c23)C(O)=O
• InChI: 1S/C13H9F2NO4/c1-5-4-20-12-9(15)8(14)2-6-10(12)16(5)3-7(11(6)17)13(18)19/h2-3,5H,4H2,1H3,(H,18,19)/t5-/m0/s1
• InChI Key: NVKWWNNJFKZNJO-YFKPBYRVSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Levofloxacin impurity F EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H315,H319,H335
• 注意書き: P261 - P280 - P302 + P352 - P304 + P340 + P312 - P305 + P351 + P338
• 危険有害性の分類: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• ターゲットの組織: Respiratory system
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable